HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

interleukin-4-Pseudomonas exotoxin

NBI-3001 appears to have an acceptable safety and toxicity profile when administered intratumorally in patients with recurrent malignant glioma
Also Known As:
IL4-Pseudomonas exotoxin; NBI-3001; NBI3001
Networked: 9 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Puri, Raj K: 5 articles (07/2005 - 07/2002)
2. Pan, Henry: 2 articles (07/2005 - 08/2003)
3. Husain, Syed R: 2 articles (10/2003 - 07/2002)
4. Kawakami, Mariko: 2 articles (10/2003 - 07/2002)
5. Kawakami, Koji: 2 articles (10/2003 - 07/2002)
6. Puri, R K: 2 articles (01/2003 - 06/2000)
7. Rand, R W: 2 articles (01/2003 - 06/2000)
8. Gitlitz, Barbara: 1 article (07/2005)
9. de Haan, Hans: 1 article (07/2005)
10. Figlin, Robert: 1 article (07/2005)

Related Diseases

1. Neoplasms (Cancer)
2. Glioma (Gliomas)
3. Glioblastoma (Glioblastoma Multiforme)
4. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

Related Drugs and Biologics

1. Interleukin-4 (Interleukin 4)
2. Interleukin-4 Receptors (Interleukin 4 Receptor)
3. Exotoxins
4. Immunotoxins (Immunotoxin)

Related Therapies and Procedures

1. Injections